presentation to the utah legislature business and … · 2020. 8. 17. · •employs over 2,000...
TRANSCRIPT
U T A H L I F E S C I E N C E S C O M P A N I E S
R E S P O N S E T O C O V I D - 1 9
P R E S E N T A T I O N T O T H E U T A H L E G I S L A T U R E B U S I N E S S A N D L A B O R I N T E R I M C O M M I T T E E
A U G U S T 18 , 2 0 2 0 , 1 : 3 0 P M
• Diagnostic Test Developers – Molecular, Genomic
and Serological
• Testing Laboratories
• Therapeutics
• PPE
MANY HAVE P IVOTED TO HELP MEET NEEDS
BE TWEEN 40-50 UTAH COMPANIES OFFER PRODUCTS ADDRESSING
COVID-19
• Employs over 2,000 people locally.
• Developed sophisticated Diagnostic that can
detect from one test up to 25 different viruses,
including COVID-19 and influenza.
• Used worldwide and manufactured here.
• Former CEO, Randy Rasmussen, a scientific expert
on molecular diagnostic testing.
B I O F I R E D I A G N O S T I C S
• Developed first FDA cleared Saliva Test for
COVID-19.
• Growth over the last year has been explosive with
over 500 employees now.
• Ease of use makes this a test growing in popularity
– Willing to work with the State of Utah.
S P E C T R U M S O L U T I O N S
• Genomic testing technology.
• Selected to partner with CDC program to
coordinate COVID-19 genomic sequencing
across the U.S.
• Can track variants and mutations.
I D b y D N A
• Employs approximately 600 at their Taylorsville
facility.
• One of only a few labs worldwide capable of
testing and certifying PPE.
• Have approved products for vendors that sell to
State of Utah.
N E L S O N L A B S
• St. George based CLIA Lab.
• Capable of running over 5,000 tests per day.
• Can do saliva or NP tests.
S O F T C E L L B I O
• Some diagnostic companies have seen
record demand and sales.
• Postponement of non-emergent procedures
have negatively impacted others.
• Clinical trials have been slowed.
I M P A C T O N O U R I N D U S T R Y
• We have products and expertise to help the State of Utah
and the nation respond to COVID-19.
• Testing at elementary and secondary schools.
• $2M of funding appropriated from legislature for research.
• The CEO of CSL/Behring, a large multi-national
manufacturer of vaccines, makes Utah his home.
INDUSTRY READY TO ASSIST
T H A N K Y O U